Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dystrophin gene that result in the absence of functional protein. Antisense-mediated exon-skipping is one of the most promising approaches for the treatment of DMD because of its capacity to correct the r...

Bibliografiset tiedot
Päätekijät:	Goyenvalle, A, Babbs, A, Powell, D, Kole, R, Fletcher, S, Wilton, S, Davies, K
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2010

Samankaltaisia teoksia

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2010)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2012)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2012)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
Tekijä: Yokota, T, et al.
Julkaistu: (2012)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
Tekijä: Lu, Q, et al.
Julkaistu: (2003)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
Tekijä: Lu, Q, et al.
Julkaistu: (2004)

Upgrading U7snRNA To Complete Efficient Rescue of Dystrophin by Exon-Skipping in DMD Patients
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2009)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
Tekijä: Wakefield, P, et al.
Julkaistu: (2000)

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study
Tekijä: Cirak, S, et al.
Julkaistu: (2011)

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Tekijä: Cirak, S, et al.
Julkaistu: (2011)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
Tekijä: Kane L Greer, et al.
Julkaistu: (2014-01-01)

Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
Tekijä: Yin, HF, et al.
Julkaistu: (2016)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
Tekijä: HaiFang Yin, et al.
Julkaistu: (2020-12-01)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
Tekijä: Sue Fletcher, et al.
Julkaistu: (2012-01-01)

Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
Tekijä: Daniel J. Ham, et al.
Julkaistu: (2019-09-01)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
Tekijä: Aoki, Y, et al.
Julkaistu: (2010)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
Tekijä: Guiraud, S, et al.
Julkaistu: (2019)

Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
Tekijä: Lu Yang, et al.
Julkaistu: (2013-01-01)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
Tekijä: Kennedy, T, et al.
Julkaistu: (2017)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
Tekijä: Zhi Yon Charles Toh, et al.
Julkaistu: (2016-01-01)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
Tekijä: Tahnee L. Kennedy, et al.
Julkaistu: (2017-10-01)

Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
Tekijä: Gang Han, et al.
Julkaistu: (2016-03-01)

Functional substitution by TAT-utrophin in dystrophin-deficient mice.
Tekijä: Kevin J Sonnemann, et al.
Julkaistu: (2009-05-01)

MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice
Tekijä: Ning Ran, et al.
Julkaistu: (2020-12-01)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
Tekijä: Justin P. Hardee, et al.
Julkaistu: (2021-03-01)

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2010)

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Tekijä: Yin, H, et al.
Julkaistu: (2009)

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2011)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
Tekijä: Baban, D, et al.
Julkaistu: (2008)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
Tekijä: Hanson, B, et al.
Julkaistu: (2022)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
Tekijä: Britt Hanson, et al.
Julkaistu: (2022-12-01)

The utrophin and dystrophin genes share similarities in genomic structure.
Tekijä: Pearce, M, et al.
Julkaistu: (1993)

AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy
Tekijä: Le Hir, M, et al.
Julkaistu: (2013)

Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle
Tekijä: Camilla Brolin, et al.
Julkaistu: (2015-01-01)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
Tekijä: Culle, M, et al.
Julkaistu: (2001)

Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping
Tekijä: Saleh Omairi, et al.
Julkaistu: (2017-12-01)

Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
Tekijä: Ugur Akpulat, et al.
Julkaistu: (2018-12-01)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
Tekijä: Annemieke Aartsma-Rus
Julkaistu: (2022-12-01)

Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2009)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
Tekijä: Cullen, M, et al.
Julkaistu: (2001)